相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Urokinase plasminogen activator receptor and its soluble form in common biopsy-proven kidney diseases and in staging of diabetic nephropathy
Chung-Ze Wu et al.
CLINICAL BIOCHEMISTRY (2015)
Soluble Urokinase Receptor and Chronic Kidney Disease
Salim S. Hayek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin Activation
Oliver Staeck et al.
TRANSPLANTATION (2015)
Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes
S. Theilade et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Sphingomyelinase-Like Phosphodiesterase 3b Expression Levels Determine Podocyte Injury Phenotypes in Glomerular Disease
Tae-Hyun Yoo et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
A New Paradigm to Understand and Treat Diabetic Neuropathy
A. Hidmark et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2014)
A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease
Takehiko Wada et al.
KIDNEY INTERNATIONAL (2014)
The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis
Bjorn Meijers et al.
KIDNEY INTERNATIONAL (2014)
Blocking αVβ3 Integrin Ligand Occupancy Inhibits the Progression of Albuminuria in Diabetic Rats
Laura A. Maile et al.
JOURNAL OF DIABETES RESEARCH (2014)
The pro-inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with incident type 2 diabetes among overweight but not obese individuals with impaired glucose regulation: effect modification by smoking and body weight status
A. Heraclides et al.
DIABETOLOGIA (2013)
Reduction and residual proteinuria are therapeutic targets in type 2 diabetes with overt nephropathy: a post hoc analysis (ORIENT-proteinuria)
Enyu Imai et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men
S. B. Haugaard et al.
DIABETIC MEDICINE (2012)
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
D. B. Sacks et al.
DIABETES CARE (2011)
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
Changli Wei et al.
NATURE MEDICINE (2011)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
suPAR: The molecular crystal ball
Maria Thuno et al.
DISEASE MARKERS (2009)
The estimation of average hazard ratios by weighted Cox regression
Michael Schemper et al.
STATISTICS IN MEDICINE (2009)
Modification of kidney barrier function by the urokinase receptor
Changli Wei et al.
NATURE MEDICINE (2008)
Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes
Per M. Humpert et al.
CARDIOVASCULAR DIABETOLOGY (2007)
Diabetic nephropathy: Diagnosis, prevention, and treatment
JL Gross et al.
DIABETES CARE (2005)
Microvascular complications of impaired glucose tolerance
JR Singleton et al.
DIABETES (2003)
Risk factors for microalbuminuria and macroalbuminuria in type 2 diabetic patients - A 9-year follow-up study
M Murussi et al.
DIABETES CARE (2002)
分享论文
